|
|
 |
DAVID B. GORNISH ASSOCIATE TELEPHONE: 215-567-2010.
EXTENSION 205
FAX: 215-751-1142
dgornish@crbcp.com
|
Mr. Gornish is a member of Caesar Rivise's ANDA Litigation Team. His litigation practice is largely focused on pharmaceutical patent infringement lawsuits arising under the Hatch-Waxman Act. For the last few years, Mr. Gornish has represented generic drug companies in several different lawsuits initiated by brand-name companies upon the generic companies' filing of Abbreviated New Drug Applications (ANDAs) and Paragraph IV certifications. A highly skilled researcher, Mr. Gornish has conducted extensive legal research directed to complex issues that arise in this nuanced and often unsettled area of the law. Additionally, Mr. Gornish has prepared numerous briefs and motions for ANDA cases at both district court and appellate levels and has been involved cumulatively in all stages of different ANDA cases, from pleadings through discovery, trial and appeal. He is registered to practice before the United States Patent and Trademark Office.
Unigene Labs, Inc. v. Apotex, Inc. (S.D.N.Y. 2006), represent generic defendant concerning nasal osteoporosis pharmaceutical drug, Fortical® (calcitonin)
Roche Palo Alto v. Apotex, Inc. (N.D. Cal. 2005), represented generic manufacturer concerning an ophthalmic NSAID solution for reducing pain and inflammation of the eyes Acular LS ® (ketorolac tromethamine)
In re '318 Patent Litigation (D. Del. 2005), represented one of seven generic manufacturers in ANDA litigation involving the Alzheimer's drug Razadyne®/Reminyl® (galanthamine).
Biovail Laboratories, Inc. v. TorPharm, Inc. (E.D. Pa. 2004), represented generic manufacturer regarding blood pressure medication Tiazac® (diltiazem hydrochloride)
Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc. (S.D.N.Y. 2003), represented generic in ANDA litigation on anti-platelet medication Plavix® (clopidogrel bisulphate)
Biovail Laboratories, Inc. v. TorPharm, Inc. (N.D. Ill. 2003), represented generic manufacturer in suit involving calcium channel blocker medication for hypertension Cardizem CD® (diltiazem hydrochloride)
AstraZeneca AB v. Apotex, Inc. (S.D.N.Y. 2002), represented one of five generic manufacturers in ANDA multi-district litigation for a gastric acid proton pump inhibitor Prilosec® (omeprazole)
Novartis Pharma. v. Apotex, Inc. (S.D.N.Y. 2002), represented generic in ANDA litigation concerning nasal osteoporosis pharmaceutical Miacalcin® (calcitonin)
Apotex, Inc. v. Eon Labs Manufacturing, Inc. (S.D.N.Y. 2002), represented patentee in litigation involving generic anti-rejection medication cyclosporin
Syntex (U.S.A.), LLC and Allergan, Inc. v. Apotex, Inc. (N.D. Cal. 2001), represented ANDA applicant involving an ophthalmic NSAID solution Acular® (ketorolac tromethamine)
Pennsylvania
New Jersey
United States District Court for the Eastern District of Pennsylvania
United States District Court for the District of New Jersey
United States Patent and Trademark Office
Published Articles:
A Patent Law Primer for Health Law Practitioners, The Health Lawyer, Vol. 21, No. 1, pp. 1-13 (October, 2008)
Co-author: The Future of Business Method Patents After Bilski, TechLaw 360 (September 24, 2008)
Patent Laws for Physician Inventors, Physician’s News Digest, Vol. XXI, No. 8, p. 10 (May, 2008)
Medical Method Patents, IPLaw 360 (Sept. 7, 2006)
Hill-Rom and the Revised Rule on Patent Abstracts, BNA Patent, Trademark & Copyright Journal, Vol. 68 No. 1690, pp. 643-645
Patent Abstracts May Now Be Used to Construe Claims, The Legal Intelligencer, Vol. 231 No. 104 (Philadelphia, Nov. 29, 2004)
Co-Author: Valuation of Intellectual Property for Litigation, Pennsylvania Bar Institute, PBI No. 2005-3991, pp. 23-52.
Firm Publications:
Patent Law for the Creative Physician, 2008
Speeches:
Physicians as Creators – How to Patent Your Inventions or Protect Your Intellectual Property and Yourself in the Process, January 16, 2008 Teleclass with The Entrepreneurial MD
Orthopedic Plate For Use in Triple Pelvic Osteotomy for Correction of Canine Hip Dysplasia, 2001 Drexel University Senior Design Competition
Pennsylvania Rising Star, Philadelphia Magazine, 2006-2007
Drexel University: B.S. Engineering
Temple University: J.D.
RETURN TO TOP OF PAGE
|
|
DAVID B. GORNISH associate
INDUSTRIES SERVED
Mechanical
Medical Devices
Pharmaceutical
Electro-mechanical
Salon Industry
Internet Businesses
ADMITTED TO PRACTICE
Pennsylvania
New Jersey
U.S. District Court, Eastern District of Pennsylvania
U.S. District Court, District of New Jersey
U.S. Patent and Trademark Office
EDUCATIONAL
BACKGROUND
Drexel University: B.S. Mechanical Engineering
Temple University School of Law: J.D.
|
|
